CMBT
Cmb.Tech N.V.
CMBT has lower modeled downside risk, despite its lower overall score.
RKLB
Rocket Lab USA, Inc.
RKLB has the edge over CMBT overall, supported by stronger modeled upside and stronger fundamentals.
CMBT Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Healthy | |
| Under pressure |
CMBT's revenue, profitability and cash flow are currently healthy, but its balance sheet is under pressure.
RKLB Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Under pressure | |
| Weak | |
| Unavailable |
RKLB's revenue is currently strong, but its profitability and cash flow are under pressure. There isn't enough data to rate its balance sheet.
CMBT PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 2.9x | $8.29 | -53% |
| Current | 6.1x | $17.61 | — |
| Fair | 7.7x | $22.14 | +26% |
| Forward | 9.8x | $17.61 | — |
| Expensive | 18x | $50.69 | +188% |
Historical ranges are pointers, not guarantees.
CMBT's PE is in its fair range at 6.1x, but its recent earnings include one-off gains. Analysts expect earnings to fall, which would put today's price at 9.8x next year's earnings.
RKLB PE Valuation
RKLB has no meaningful PE right now: it lost money over the past year.
CMBT Forward outlook
| Metric | Outlook |
|---|---|
| Strongly deteriorating | |
| Strong decline | |
| Decline | |
| Strongly weakening | |
| Limited | |
| Low |
Analysts expect CMBT's earnings and revenue to decline, with profitability weakening. However, they disagree widely on these estimates.
RKLB Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Low |
RKLB has the edge over CMBT on the outlook, with more favorable earnings and revenue expectations.
CMBT Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.79 | -38% |
| Q2 2026 | $2.89 | +131% |
| Q1 2026 | $1.70 | -21% |
| Q4 2025 | $0.66 | -85% |
| Q3 2025 | $0.83 | -86% |
| Q2 2025 | $1.25 | -79% |
| Q1 2025 | $2.15 | -63% |
| Q4 2024 | $4.36 | +0.9% |
| Q3 2024 | $5.97 | +73% |
CMBT has the edge over RKLB on earnings quality, reporting a profit while its opponent remains loss making.
RKLB Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$0.36 | +$0.03 |
| Q2 2026 | -$0.27 | +$0.19 |
| Q1 2026 | -$0.32 | +$0.09 |
| Q4 2025 | -$0.37 | +$0.01 |
| Q3 2025 | -$0.39 | -$0.02 |
| Q2 2025 | -$0.46 | -$0.11 |
| Q1 2025 | -$0.41 | -$0.04 |
| Q4 2024 | -$0.38 | $0.00 |
RKLB is still losing money, but less than at its worst: $0.36 per share over the past year, against $0.46 at its worst in mid-2025.
CMBT Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $691.4M | +78% |
| Q1 2026 | $519.6M | +121% |
| Q4 2025 | $589M | +161% |
| Q3 2025 | $454.2M | +105% |
| Q2 2025 | $387.8M | +55% |
| Q1 2025 | $235M | -1.6% |
| Q4 2024 | $226M | -19% |
| Q3 2024 | $221.8M | -18% |
CMBT's revenue is recovering but still below its 2020 peak: $691M last quarter, up 78% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 41% | +25 points |
| Q1 2026 | 33% | -11 points |
| Q4 2025 | 28% | -33 points |
| Q3 2025 | 28% | -33 points |
| Q2 2025 | 15% | -71 points |
| Q1 2025 | 44% | +4.3 points |
| Q4 2024 | 61% | +23 points |
| Q3 2024 | 62% | +20 points |
CMBT has the edge over RKLB on profitability, with a higher operating margin.
RKLB Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $267.8M | +73% |
| Q2 2026 | $234.1M | +62% |
| Q1 2026 | $200.3M | +63% |
| Q4 2025 | $179.7M | +36% |
| Q3 2025 | $155.1M | +48% |
| Q2 2025 | $144.5M | +36% |
| Q1 2025 | $122.6M | +32% |
| Q4 2024 | $132.4M | +121% |
RKLB's revenue has grown year over year every quarter since late 2021: $268M last quarter, up 73% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -30% | +8.5 points |
| Q2 2026 | -25% | +17 points |
| Q1 2026 | -28% | +20 points |
| Q4 2025 | -28% | +11 points |
| Q3 2025 | -38% | +12 points |
| Q2 2025 | -41% | -0.5 points |
| Q1 2025 | -48% | -1.9 points |
| Q4 2024 | -39% | +41 points |
RKLB's operating margin was −30% last quarter, up 8.5 points from the same quarter a year ago.
CMBT Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $249.9M | +$542.3M |
| Q1 2026 | $167.4M | +$364.9M |
| Q4 2025 | $11.7M | +$322M |
| Q3 2025 | -$133.8M | +$26.4M |
| Q2 2025 | -$292.4M | -$28.1M |
| Q1 2025 | -$197.6M | -330% |
| Q4 2024 | -$310.3M | -262% |
| Q3 2024 | -$160.2M | -280% |
CMBT has the edge over RKLB on cash generation, producing positive trailing cash flow while its opponent burns cash.
RKLB Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$23.9M | +$45.5M |
| Q2 2026 | -$110.1M | -$54.8M |
| Q1 2026 | -$77.4M | +$5.5M |
| Q4 2025 | -$114.2M | -$90.2M |
| Q3 2025 | -$69.4M | -$27.5M |
| Q2 2025 | -$55.3M | -$26.9M |
| Q1 2025 | -$82.9M | -$61.1M |
| Q4 2024 | -$23.9M | +$28.7M |
RKLB has burned cash in almost every quarter: −$326M over the past year, against −$232M the year before.
CMBT Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | -- |
| 1 year | +49% | +96M shares |
| 3 years | +44% | +88.3M shares |
| 5 years | +38% | +80M shares |
| Available history | +83% | +132M shares |
CMBT has 290M diluted shares, up 49% from a year ago.
| Quarter | Spent |
|---|---|
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | $572,205 |
| Q3 2024 | $716,108 |
CMBT hasn't bought back shares in the past year.
RKLB Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +3.6% | +22.6M shares |
| 1 year | +23% | +124M shares |
| 3 years | +35% | +168M shares |
| 5 years | +46% | +204M shares |
RKLB has the edge over CMBT on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q4 2020 | — |
| Q2 2020 | — |
| Q1 2020 | — |
CMBT Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | 4.0x | Elevated |
| Q1 2026 | 4.4x | High |
| Q4 2025 | 6.3x | High |
| Q3 2025 | 7.3x | High |
| Q2 2025 | 7.3x | High |
| Q1 2025 | 6.6x | High |
| Q4 2024 | 2.2x | Moderate |
| Q3 2024 | 2.0x | Healthy |
CMBT's net debt is about 4.0 years of its operating earnings (EBITDA), down from 7.3 years a year ago.
RKLB Net Leverage
RKLB's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
CMBT Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 52.6 | Neutral |
| Stochastic | 33.0 | Neutral |
CMBT's weekly RSI is 53 (neutral) and its Stochastic is 33 (neutral).
RKLB Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 46.8 | Neutral |
| Stochastic | 27.6 | Neutral |
RKLB's weekly RSI is 47 (neutral) and its Stochastic is 28 (neutral).
CMBT PE vs Industrials Sector
| Metric | CMBT | Sector median | Relative |
|---|---|---|---|
| PE | 6.1x | 24x | 75% below |
| PE % | 45 | 58 | 13 pts below |
CMBT is trading at 6.1x earnings, a 75% discount to the Industrials sector's median of 24x, though its recent earnings include one-off gains.
RKLB PE vs Industrials Sector
RKLB has no meaningful PE right now: it lost money over the past year.
CMBT Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $18.5 | 4.7% below |
| 20 week MA | $17.7 | 0.5% below |
| 50 week MA | $14.8 | 19% above |
| 100 week MA | $12.2 | 45% above |
| 200 week MA | $14.3 | 23% above |
CMBT has slipped below its 8- and 20-week averages, though it's still 23% above its 200-week average.
RKLB Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $61.4 | 4.3% above |
| 20 week MA | $68.1 | 5.9% below |
| 50 week MA | $77.6 | 17% below |
| 100 week MA | $56.5 | 13% above |
| 200 week MA | $31.4 | 104% above |
RKLB's trend is mixed: it's above three of its five weekly moving averages, and 104% above its 200-week average.
CMBT Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $12.2 | $8.08 | -34% |
| 2021 | $8.08 | $8.81 | +9% |
| 2022 | $8.81 | $17.2 | +96% |
| 2023 | $17.2 | $17.6 | +2% |
| 2024 | $17.6 | $10.0 | -43% |
| 2025 | $10.0 | $9.70 | -3.3% |
| 2026 YTD | $9.70 | $17.6 | +82% |
CMBT has the edge over RKLB on returns for 2026, with the stronger performance.
RKLB Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.82 | $10.3 | +4.9% |
| 2021 | $10.3 | $12.0 | +17% |
| 2022 | $12.0 | $3.77 | -69% |
| 2023 | $3.77 | $5.53 | +47% |
| 2024 | $5.53 | $27.2 | +392% |
| 2025 | $27.2 | $70.7 | +160% |
| 2026 YTD | $70.7 | $64.1 | -9.3% |
RKLB's yearly returns have swung widely, from +392% in 2024 to −69% in 2022. It's down 9.3% so far in 2026.